PL370174A1 - 2-guanidino-4-heterocyclylquinazolines - Google Patents
2-guanidino-4-heterocyclylquinazolinesInfo
- Publication number
- PL370174A1 PL370174A1 PL02370174A PL37017402A PL370174A1 PL 370174 A1 PL370174 A1 PL 370174A1 PL 02370174 A PL02370174 A PL 02370174A PL 37017402 A PL37017402 A PL 37017402A PL 370174 A1 PL370174 A1 PL 370174A1
- Authority
- PL
- Poland
- Prior art keywords
- heterocyclylquinazolines
- guanidino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10161767A DE10161767A1 (de) | 2001-12-15 | 2001-12-15 | 2-Guanidino-4-heterocyclyl-chinazoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL370174A1 true PL370174A1 (en) | 2005-05-16 |
Family
ID=7709413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02370174A PL370174A1 (en) | 2001-12-15 | 2002-11-21 | 2-guanidino-4-heterocyclylquinazolines |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050113396A1 (pt) |
| EP (1) | EP1453823A1 (pt) |
| KR (1) | KR20040065233A (pt) |
| AR (1) | AR037821A1 (pt) |
| AU (1) | AU2002342918A1 (pt) |
| BR (1) | BR0214875A (pt) |
| CA (1) | CA2470030A1 (pt) |
| DE (1) | DE10161767A1 (pt) |
| MX (1) | MXPA04005692A (pt) |
| PL (1) | PL370174A1 (pt) |
| WO (1) | WO2003051866A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10312963A1 (de) * | 2003-03-24 | 2004-10-07 | Aventis Pharma Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| US7241775B2 (en) | 2003-03-24 | 2007-07-10 | Sanofi-Aventis Deutschland Gmbh | Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines |
| KR20110050718A (ko) | 2008-09-02 | 2011-05-16 | 사노피-아벤티스 | 치환된 아미노인단 및 그의 유사체, 및 그의 제약 용도 |
| CN103819403B (zh) | 2008-12-31 | 2017-01-04 | 阿德利克斯公司 | 用于治疗与体液潴留或盐超负荷有关的病症和胃肠道病症的化合物和方法 |
| WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| AU2013304812B2 (en) | 2012-08-21 | 2016-06-09 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| KR20230132619A (ko) | 2013-04-12 | 2023-09-15 | 알데릭스, 인코포레이티드 | Nhe3-결합 화합물 및 포스페이트 수송을 저해하는 방법 |
| SG11201700398RA (en) | 2014-07-25 | 2017-02-27 | Taisho Pharmaceutical Co Ltd | Phenyl tetrahydroisoquinoline compound substituted with heteroaryl |
| EP3565811A1 (en) | 2017-01-09 | 2019-11-13 | Ardelyx, Inc. | Inhibitors of nhe-mediated antiport |
| AU2018205400B2 (en) | 2017-01-09 | 2022-07-14 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
| BR112020002322A2 (pt) | 2017-08-04 | 2020-09-01 | Ardelyx, Inc. | derivados de ácido glicirretinínico para o tratamento de hipercalemia |
| AU2020218255A1 (en) | 2019-02-07 | 2021-09-09 | Ardelyx, Inc. | Glycyrrhetinic acid derivatives for use in treating hyperkalemia |
| WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US396495A (en) * | 1889-01-22 | Ink-bottle and attachment therefor | ||
| US395526A (en) * | 1889-01-01 | Tenoning-ivjachine | ||
| NL131733C (pt) * | 1961-06-20 | |||
| NL292083A (pt) * | 1962-09-18 | |||
| US3950526A (en) * | 1970-04-20 | 1976-04-13 | Sumitomo Chemical Company, Limited | Quinazoline derivatives in pharmaceutical compositions for treating pain and inflammation |
| BE795970A (fr) * | 1972-02-29 | 1973-08-27 | Pfizer | Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant |
| US3900476A (en) * | 1973-05-17 | 1975-08-19 | Upjohn Co | 2(2'-pyrimidylamino)quinazolines and their preparation |
| US3956495A (en) * | 1973-10-30 | 1976-05-11 | Eli Lilly And Company | 2,4-Diaminoquinazolines as antithrombotic agents |
| IL102764A0 (en) * | 1991-08-16 | 1993-01-31 | Merck & Co Inc | Quinazoline derivatives,and pharmaceutical compositions containing them |
| DE19633966A1 (de) * | 1996-08-22 | 1998-02-26 | Hoechst Ag | Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE10019062A1 (de) * | 2000-04-18 | 2001-10-25 | Merck Patent Gmbh | 2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren |
| KR100383080B1 (ko) * | 2000-09-05 | 2003-05-12 | 주식회사 포스코 | 조절된 아민기 밀도와 공간을 제공하는 분자층을 표면에포함하는 기질 및 이의 제조방법 |
| US20030139431A1 (en) * | 2001-09-24 | 2003-07-24 | Kawakami Joel K. | Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors |
-
2001
- 2001-12-15 DE DE10161767A patent/DE10161767A1/de not_active Withdrawn
-
2002
- 2002-11-21 BR BR0214875-7A patent/BR0214875A/pt not_active Application Discontinuation
- 2002-11-21 AU AU2002342918A patent/AU2002342918A1/en not_active Abandoned
- 2002-11-21 WO PCT/EP2002/013061 patent/WO2003051866A1/de not_active Application Discontinuation
- 2002-11-21 EP EP02779568A patent/EP1453823A1/de not_active Withdrawn
- 2002-11-21 US US10/498,806 patent/US20050113396A1/en not_active Abandoned
- 2002-11-21 PL PL02370174A patent/PL370174A1/xx unknown
- 2002-11-21 CA CA002470030A patent/CA2470030A1/en not_active Abandoned
- 2002-11-21 KR KR10-2004-7008399A patent/KR20040065233A/ko not_active Application Discontinuation
- 2002-11-21 MX MXPA04005692A patent/MXPA04005692A/es unknown
- 2002-12-13 AR ARP020104838A patent/AR037821A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002342918A1 (en) | 2003-06-30 |
| KR20040065233A (ko) | 2004-07-21 |
| AR037821A1 (es) | 2004-12-09 |
| DE10161767A1 (de) | 2003-06-26 |
| MXPA04005692A (es) | 2004-12-06 |
| EP1453823A1 (de) | 2004-09-08 |
| US20050113396A1 (en) | 2005-05-26 |
| BR0214875A (pt) | 2004-12-28 |
| WO2003051866A1 (de) | 2003-06-26 |
| CA2470030A1 (en) | 2003-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60217162D1 (en) | Tetrafluorethen-perfluorbutylethen-copolymer | |
| DE60209787D1 (en) | Flächiges implantat | |
| DE50202400D1 (en) | Baw-resonator | |
| DE50201180D1 (en) | Organopolysiloxan/polyharnstoff/polyurethan-blockcopolymere | |
| DE60213216D1 (en) | Metalloproteinaseinhibitoren | |
| DE50209614D1 (en) | 2-heteroarylcarbonsäureamide | |
| DE60217478D1 (en) | Sychrongleichrichter | |
| DE50211022D1 (en) | Heteroarylcarbonsäureamide | |
| DE60214551D1 (en) | Modulares airbagaufblassystem | |
| DE60210819D1 (en) | Pyrazolopyridazinderivate | |
| DE60141364D1 (en) | Polyphenylensulfidharzzusammensetzung | |
| DE50202633D1 (en) | Ophthalmoskop | |
| DE60141362D1 (en) | Ösophagus-stoma-knopf | |
| AU2002360430A8 (en) | 14-methyl-epothilones | |
| PL370174A1 (en) | 2-guanidino-4-heterocyclylquinazolines | |
| DE60107296D1 (en) | Kabelverstärkerverbindungsanordnung | |
| DE60204140D1 (en) | 5-ethyl-imidazotriazinone | |
| DE60216319D1 (en) | Heteroaryl-substituierte aminocyclohexan-derivate | |
| DE50206483D1 (en) | Displaymodul | |
| DE50203686D1 (en) | Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate | |
| DE50201028D1 (en) | Diarylgelbpigmentpraeparationen | |
| DE50214962D1 (en) | Heterocyclylarylsulfonamide | |
| DE60206072D1 (en) | Aroylpyridinone | |
| AU2002313943A8 (en) | Electromobile | |
| AU2001100134A4 (en) | Enviro-trap |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |